Low dose inhaled corticosteroids and the prevention of death from asthma

Thorax

Volumn 56, Issue SUPPL. 2, 2001, Pages

  Kips, J C ^a   Pauwels, R A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; THEOPHYLLINE;

ADOLESCENT; ADULT; ASTHMA; CHILD; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; HOSPITALIZATION; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; ASTHMA; DRUG ADMINISTRATION SCHEDULE; GLUCOCORTICOIDS; HUMANS; SURVIVAL RATE;

EID: 18844475498     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Asthma. From bronchoconstriction to airways inflammation and remodeling
2. Current practice and future trends in clinical trials in asthma
3. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics
4. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma
5. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
6. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol
7. Effect of inhaled formoterol and budesonide on exacerbations of asthma
8. Long-term effects of budesonide or nedocromil in children with asthma
9. A comparison of beclomethasone, salmeterol, and placebo in children with asthma
10. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial
11. Combined salmeterol 50 μg and fluticasone propionate 250 μg in the diskus device for the treatment of asthma
12. A double-blind study on the effect of inhaled corticosteroids on plasma protein exudation in asthma
13. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group Controlled trial
14. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
15. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma
16. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study
17. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: A placebo-controlled study
18. Clinical control and histopathological outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
19. Inhaled steroids and the risk of hospitalization for asthma
20. Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in prevalence of asthma
21. Inhaled corticosteroids and the prevention of readmission to hospital for asthma
22. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma
23. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use
24. Low-dose inhaled corticosteroids and the prevention of death from asthma
25. Age specific trends in asthma mortality in England and Wales, 1983-96: Results of an observational study
26. Descriptive epidemiology of asthma
27. Observations on asthma mortality
28. Trends in prevalence and severity of childhood asthma
29. Asthma: United States 1980-1990
30. Changing patterns of asthma mortality. Identifying target populations at high risk
31. Long-term survival of a cohort of community residents with asthma
32. Occurrence, predictors, and consequences of adult asthma in NHANESI and follow-up survey
33. Mortality of adults with asthma: A prospective cohort study
34. Prognosis in adult asthma: A national study
35. Mortality and markers of risk of asthma death among 1,075 outpatients with asthma
36. Mortality in adults with self-reported asthma
37. Accuracy of recording of deaths from asthma in the UK: The false negative rate
38. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease
39. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?
40. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma
41. Fatal asthma
42. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma
43. Patterns of asthma mortality in Philadelphia from 1969 to 1991
44. Asthma mortality: Summary of a round table discussion, New York, January 1997
45. Differences between asthma exacerbations and poor asthma control
46. Pediatric asthma deaths in Victoria: The mild are at risk
47. Asthma mortality rate in Swedish children and young adults 1973-88
48. Underdiagnosis of asthma: Is the doctor or the patient to blame? The DIMCA project
49. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma
50. Psychiatric and medical features of near fatal asthma
51. A case-control study of deaths from asthma
52. Death from asthma in two regions of England
53. Death from asthma
54. Controlled investigation of deaths from asthma in hospitals in the North East Thames region
55. Asthma mortality in Birmingham 1975-7: 53 deaths
56. Asthma mortality: A review of recent experience in New Zealand
57. Fatal and near-fatal asthma
58. Prevention of fatal asthma
59. Edinburgh Emergency Asthma Admission Service: Report on 10 years' experience
60. Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals
61. Use of inhaled medications and urgent care services. Study of Canadian asthma patients
62. Asthma survey demonstrates that the goals of the NHLBI have not been accomplished
63. Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe (AIRE) study
64. Are asthma medications and management related to deaths from asthma?
65. Undertreatment in a nonselected population of adult patients with asthma
66. Morbidity from asthma in relation to regular treatment: A community based study
67. Are young adults with asthma treated sufficiently with inhaled steroids? A population-based study of prescription data from 1991 and 1994
68. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients
69. Medication, chronic illness and identity: The perspective of people with asthma
70. Poverty, race, and medication use are correlates of asthma hospitalization rates
71. Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma
72. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma
73. Management of chronic disease by practitioners and patients: Are we teaching the wrong things?
74. Evaluating an educational intervention to improve the treatment of asthma in four European countries
75. Long-term effects of asthma education for physicians on patient satisfaction and use of health services
76. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?
77. The effect of inhaled corticosteroids on the maximal degree of airway narrowing, to methacholine in asthmatic subjects
78. Effects of fluticasone propionate on methaeholine dose-response curves in nonsmoking atopic asthmatics
79. Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma
80. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
81. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment
82. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
83. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma
84. Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: A placebo-controlled parallel group study
85. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking
86. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: What lessons have been learned?
87. Perspectives in beta 2-agonist therapy: Vox clamantis in deserto vel lux in tenebris?
88. A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma
89. Regular inhaled beta agonist in asthma: Effects on exacerbations and lung function
90. Exacerbations of asthma: A descriptive study of 425 severe exacerbations
91. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma
92. Case-control study of salmeterol and near-fatal attacks of asthma